Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Fort Worth, TX
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Houston, TX
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
San Antonio, TX
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
The Woodlands, TX
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
The Woodlands, TX
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Burlington, VT
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Chesapeake, VA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Chesapeake, VA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Fairfax, VA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Fairfax, VA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Olympia, WA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Olympia, WA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Spokane, WA
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Madison, WI
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Madison, WI
Click here to add this to my saved trials
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated:  3/21/2011
Clinical Research Facility
mi
from
Milwaukee, WI
4968 Post-approval Study
Medtronic Model 4968 CapSure Epi® Steroid-Eluting Bipolar Epicardial Pacing Lead Post-approval Study
Status: Enrolling
Updated: 3/21/2011
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
The RAS, Fibrinolysis and Cardiopulmonary Bypass
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Status: Enrolling
Updated:  3/22/2011
TN Valley Healthcare System
mi
from
Nashville, TN
The RAS, Fibrinolysis and Cardiopulmonary Bypass
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/22/2011
TN Valley Healthcare System
mi
from
Nashville, TN
Click here to add this to my saved trials
The RAS, Fibrinolysis and Cardiopulmonary Bypass
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Status: Enrolling
Updated:  3/22/2011
Vanderbilt University
mi
from
Nashville, TN
The RAS, Fibrinolysis and Cardiopulmonary Bypass
The RAS, Fibrinolysis and Cardiopulmonary Bypass
Status: Enrolling
Updated: 3/22/2011
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
A Single Masked, Randomized Controlled Study to Assess EFficacy of Ozurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Diabetic Macular Edema
Status: Archived
Updated:  4/8/2011
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Ozurdex as Adjunct to Avastin Compared to Avastin Alone in Treatment of Patients With Diabetic Macular Edema
A Single Masked, Randomized Controlled Study to Assess EFficacy of Ozurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Diabetic Macular Edema
Status: Archived
Updated: 4/8/2011
Raj K. Maturi, MD
mi
from
Indianapolis, IN
Radiation Dose From Computed Tomography Before and After Implementation of a High Pitch Dual Spiral Technique
Radiation Dose From Computed Tomography Before and After Implementation of a High Pitch Dual Spiral Technique
Status: Enrolling
Updated:  4/8/2011
William Beaumont Hospital-Royal Oak
mi
from
Royal Oak, MI
Radiation Dose From Computed Tomography Before and After Implementation of a High Pitch Dual Spiral Technique
Radiation Dose From Computed Tomography Before and After Implementation of a High Pitch Dual Spiral Technique
Status: Enrolling
Updated: 4/8/2011
William Beaumont Hospital-Royal Oak
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
Statin Induced Augmentation of Circulating Endothelial Progenitor Cells and Myocardial Viability in Patients With Ischemic and Nonischemic Cardiomyopathy
Status: Enrolling
Updated:  4/12/2011
Ohio State University
mi
from
Columbus, OH
Statin Therapy for Ischemic and Nonischemic Cardiomyopathy
Statin Induced Augmentation of Circulating Endothelial Progenitor Cells and Myocardial Viability in Patients With Ischemic and Nonischemic Cardiomyopathy
Status: Enrolling
Updated: 4/12/2011
Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Carl T. Hayden Medical Research Foundation
mi
from
Phoenix, AZ
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Carl T. Hayden Medical Research Foundation
mi
from
Phoenix, AZ
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
University of California at San Francisco
mi
from
San Francisco, CA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
University of Miami
mi
from
Miami, FL
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Northwestern University
mi
from
Chicago, IL
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Tufts Medical Center
mi
from
Boston, MA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Wayne State University
mi
from
Detroit, MI
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Michigan State University
mi
from
East Lansing, MI
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Michigan State University
mi
from
East Lansing, MI
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Gotham Cardiovascular Research PC
mi
from
New York, NY
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Gotham Cardiovascular Research PC
mi
from
New York, NY
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
New York University School of Medicine
mi
from
New York, NY
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
New York University School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Baylor College of Medicine
mi
from
Houston, TX
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Western Institute for Biomedical Research
mi
from
Salt Lake City, UT
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Western Institute for Biomedical Research
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
Univ of Washington
mi
from
Seattle, WA
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated:  4/13/2011
West Virginia University
mi
from
Morgantown, WV
SmartRisk Stroke Prediction by MRI of Carotid Disease
Assessment of MRI-based Prediction of Stroke and Other Cerebrovascular Symptoms Arising From Carotid Atherosclerotic Disease in Asymptomatic Individuals
Status: Enrolling
Updated: 4/13/2011
West Virginia University
mi
from
Morgantown, WV
Click here to add this to my saved trials
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
Status: Enrolling
Updated:  4/19/2011
Stanford University School of Medicine
mi
from
Stanford, CA
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
Clinical Trial of Pioglitazone for Prevention of Cardiac Allograft Vasculopathy After Heart Transplantation
Status: Enrolling
Updated: 4/19/2011
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
A Study Assessing The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Subcutaneous Bolus And Subcutaneous Infusion Of Cenderitide In Patients With Chronic Heart Failure With Volume Overload (HF)
Status: Enrolling
Updated:  5/9/2011
Orange County Research Center
mi
from
Tustin, CA
A Study Assessing The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Subcutaneous Bolus And Subcutaneous Infusion Of Cenderitide In Patients With Chronic Heart Failure With Volume Overload (HF)
Status: Enrolling
Updated: 5/9/2011
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
A Study Assessing The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Subcutaneous Bolus And Subcutaneous Infusion Of Cenderitide In Patients With Chronic Heart Failure With Volume Overload (HF)
Status: Enrolling
Updated:  5/9/2011
Benchmark Research
mi
from
Metairie, LA
A Study Assessing The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Subcutaneous Bolus And Subcutaneous Infusion Of Cenderitide In Patients With Chronic Heart Failure With Volume Overload (HF)
Status: Enrolling
Updated: 5/9/2011
Benchmark Research
mi
from
Metairie, LA
Click here to add this to my saved trials
A Study Assessing The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Subcutaneous Bolus And Subcutaneous Infusion Of Cenderitide In Patients With Chronic Heart Failure With Volume Overload (HF)
Status: Enrolling
Updated:  5/9/2011
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
A Study Assessing The Pharmacokinetics, Pharmacodynamics, Safety And Tolerability Of Subcutaneous Bolus And Subcutaneous Infusion Of Cenderitide In Patients With Chronic Heart Failure With Volume Overload (HF)
Status: Enrolling
Updated: 5/9/2011
Hennepin County Medical Center - Minneapolis
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Dose Titration of Droxidopa in Patients With Spinal Cord Injury
A Dose Response Trial of Droxidopa to Treat Hypotension in Persons With SCI
Status: Enrolling
Updated:  5/13/2011
James J Peters VA Medical Center
mi
from
Bronx, NY
A Dose Titration of Droxidopa in Patients With Spinal Cord Injury
A Dose Response Trial of Droxidopa to Treat Hypotension in Persons With SCI
Status: Enrolling
Updated: 5/13/2011
James J Peters VA Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography
Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography
Status: Enrolling
Updated:  5/16/2011
Massachusetts General Hospital
mi
from
Boston, MA
Multicenter Study to Rule Out Myocardial Infarction by Cardiac Computed Tomography
Rule Out Myocardial Ischemia/Infarction by Computer Assisted Tomography
Status: Enrolling
Updated: 5/16/2011
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus Using Regadenoson Stress Cardiac Magnetic Resonance Imaging
Status: Enrolling
Updated:  5/26/2011
University of Virginia
mi
from
Charlottesville, VA
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus
Less Invasive Detection and Treatment of Very Early Coronary Artery Disease in Patients With Diabetes Mellitus Using Regadenoson Stress Cardiac Magnetic Resonance Imaging
Status: Enrolling
Updated: 5/26/2011
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia ("POTS" -- Postural Orthostatic Tachycardia Syndrome)Later in Life -- a Retrospective Analysis
Status: Enrolling
Updated:  6/5/2011
Total Eye Care
mi
from
Colleyville, TX
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia Later in Life
Head Circumference Growth in Children With Ehlers-Danlos Syndrome Who Develop Dysautonomia ("POTS" -- Postural Orthostatic Tachycardia Syndrome)Later in Life -- a Retrospective Analysis
Status: Enrolling
Updated: 6/5/2011
Total Eye Care
mi
from
Colleyville, TX
Click here to add this to my saved trials
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated:  6/7/2011
Transplant Center, University of Minnesota Medical School
mi
from
Minneapolis, MN
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated: 6/7/2011
Transplant Center, University of Minnesota Medical School
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated:  6/7/2011
Division of Transplantation, Drexel University College of Medicine
mi
from
Philadelphia, PA
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated: 6/7/2011
Division of Transplantation, Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated:  6/7/2011
Service de Nephrologie et Transplantation, Hopital Lapeyronie, Centre Hospitalier Universitaire Montpellier
mi
from
Montpellier,
Reparixin in Prevention of Delayed Graft Dysfunction After Kidney Transplantation
A Phase 2, Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group (3 Arms) Pilot Study to Assess the Efficacy, the Safety and the Pharmacokinetics of Two Treatment Schedules of Reparixin in the Prevention of Delayed Graft Function After Kidney Transplantation in High Risk Patients
Status: Enrolling
Updated: 6/7/2011
Service de Nephrologie et Transplantation, Hopital Lapeyronie, Centre Hospitalier Universitaire Montpellier
mi
from
Montpellier,
Click here to add this to my saved trials
Catheter Ablation for Atrial Fibrillation and Heart Failure
Pulmonary Vein Isolation for Rhythm Control in Patients With Atrial Fibrillation and Left Ventricular Dysfunction: A Pilot Study
Status: Enrolling
Updated:  6/8/2011
The Valley Hospital
mi
from
Ridgewood, NJ
Catheter Ablation for Atrial Fibrillation and Heart Failure
Pulmonary Vein Isolation for Rhythm Control in Patients With Atrial Fibrillation and Left Ventricular Dysfunction: A Pilot Study
Status: Enrolling
Updated: 6/8/2011
The Valley Hospital
mi
from
Ridgewood, NJ
Click here to add this to my saved trials
Catheter Ablation for Atrial Fibrillation and Heart Failure
Pulmonary Vein Isolation for Rhythm Control in Patients With Atrial Fibrillation and Left Ventricular Dysfunction: A Pilot Study
Status: Enrolling
Updated:  6/8/2011
St.Luke's-Roosevelt Hospital
mi
from
New York, NY
Catheter Ablation for Atrial Fibrillation and Heart Failure
Pulmonary Vein Isolation for Rhythm Control in Patients With Atrial Fibrillation and Left Ventricular Dysfunction: A Pilot Study
Status: Enrolling
Updated: 6/8/2011
St.Luke's-Roosevelt Hospital
mi
from
New York, NY
Click here to add this to my saved trials
The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
Status: Enrolling
Updated:  6/14/2011
Atlanta Medical Center
mi
from
Atlanta, GA
The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
Status: Enrolling
Updated: 6/14/2011
Atlanta Medical Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
Status: Enrolling
Updated:  6/14/2011
Grady Memorial Hospital
mi
from
Atlanta, GA
The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
The Use of Near Infrared Spectroscopy in the Diagnosis of Acute Compartment Syndrome
Status: Enrolling
Updated: 6/14/2011
Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Low-Molecular-Weight Heparin for DVT Prophylaxis After Open Reduction and Internal Fixation of Ankle Fractures: A Randomized, Prospective Trial
Status: Enrolling
Updated:  6/15/2011
Erlanger Medical Center
mi
from
Chattanooga, TN
Low-Molecular-Weight Heparin (LMWH) for Deep Venous Thrombosis (DVT) Prophylaxis
Low-Molecular-Weight Heparin for DVT Prophylaxis After Open Reduction and Internal Fixation of Ankle Fractures: A Randomized, Prospective Trial
Status: Enrolling
Updated: 6/15/2011
Erlanger Medical Center
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease
Validation of the CardioSond Sonospectrographic Digital Electronic Stethoscope in Diagnosing Coronary Artery Disease Versus CT Angiography
Status: Enrolling
Updated:  6/15/2011
MedStar Washington Hospital Center
mi
from
Washington,
Evaluation of the CardioSond Electronic Stethoscope in the Detection of Coronary Artery Disease
Validation of the CardioSond Sonospectrographic Digital Electronic Stethoscope in Diagnosing Coronary Artery Disease Versus CT Angiography
Status: Enrolling
Updated: 6/15/2011
MedStar Washington Hospital Center
mi
from
Washington,
Click here to add this to my saved trials
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
Status: Enrolling
Updated:  6/15/2011
University of Alabama at Birmingham
mi
from
Birmingham, AL
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
Status: Enrolling
Updated: 6/15/2011
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
Status: Enrolling
Updated:  6/15/2011
Scottsdale Health Care - Osborn Campus
mi
from
Scottsdale, AZ
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
GRAVITAS: Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
Status: Enrolling
Updated: 6/15/2011
Scottsdale Health Care - Osborn Campus
mi
from
Scottsdale, AZ
Click here to add this to my saved trials